Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/16/2025

Bronchiolitis in Young Children

Definition and Epidemiology

  • Bronchiolitis is a disorder commonly caused by viral lower respiratory tract infection in infants, characterized by acute inflammation, edema, and necrosis of epithelial cells lining small airways, and increased mucus production 1
  • It is the most common lower respiratory infection in young children and the most common cause of hospitalization in those aged less than 1 year 2
  • The American Academy of Pediatrics (AAP) clinical practice guidelines specifically define the target population for bronchiolitis management as children from 1 month through 23 months of age 1, 3
  • Approximately 90% of children are infected with Respiratory Syncytial Virus (RSV), the most common cause of bronchiolitis, within the first 2 years of life 4
  • Up to 40% of children infected with RSV will experience lower respiratory tract infection during their initial infection 1

Age Distribution and Risk Factors

  • Infants younger than 12 weeks are at higher risk for severe disease 5
  • Bronchiolitis leads to more than 90,000 hospitalizations annually in the United States, with most hospitalizations occurring in infants less than 1 year old 4

Clinical Presentation by Age

  • In infants 1-12 months, bronchiolitis is more likely to present with increased work of breathing, including tachypnea, nasal flaring, and intercostal retractions 1, 6
  • In infants 1-12 months, there is a higher risk of apnea, particularly in those younger than 1 month and in premature infants 6
  • In children 12-24 months, bronchiolitis typically presents with rhinitis and cough that may progress to wheezing and rales 1
  • In children 12-24 months, they are generally able to compensate for increased respiratory effort better than younger infants 6

High-Risk Groups

  • Premature infants, especially those born before 32 weeks gestation, are at higher risk for severe disease 1
  • Children with hemodynamically significant congenital heart disease are at higher risk for severe disease 1
  • Children with chronic lung disease of prematurity are at higher risk for severe disease 1
  • Children with neuromuscular disease or immunodeficiency are at higher risk for severe disease 1, 5

Clinical Course

  • Bronchiolitis is typically self-limiting, with most children recovering within 2-3 weeks 2
  • The mean time to cough resolution is 8-15 days 2
  • 90% of children are cough-free by day 21 2
  • Children with persistent symptoms beyond 4 weeks may represent a different clinical problem, sometimes termed "post-bronchiolitis syndrome" 2

Important Considerations

  • The AAP guidelines specifically exclude children with immunodeficiencies, underlying respiratory illnesses, neuromuscular disease, or hemodynamically significant congenital heart disease from general management recommendations 1
  • Children outside the 1-24 month age range may develop bronchiolitis-like illnesses but may have different clinical presentations, management needs, and outcomes 1
  • Neonates (under 1 month) with bronchiolitis symptoms require special consideration due to their higher risk of severe disease and apnea 6

Diagnosis and Management of Bronchiolitis

Clinical Presentation and Diagnosis

  • The American Academy of Pediatrics recommends that bronchiolitis should be diagnosed based on history and physical examination alone, as this infant demonstrates the pathognomonic features of the disease, including low-grade fever, dry cough, bilateral wheezing, tachypnea, and hyperinflation on chest X-ray in a child under 2 years of age 7, 8, 9
  • The clinical criteria that confirm the diagnosis of bronchiolitis include acute inflammation of small airways in a child under 2 years, tachypnea, wheezing, and/or crackles following upper respiratory prodrome, and increased respiratory effort 7, 8, 9
  • The diagnosis of bronchiolitis is regardless of the specific viral etiology, and routine viral testing is not necessary as it does not change management 7, 8, 9

Differential Diagnosis

  • Asthma is unlikely in this 7-month-old infant because it is extremely rare as a first presentation at this age, and the acute febrile illness with 3-day prodrome points to infectious etiology 7, 9, 10
  • Sinusitis is incorrect because it does not cause hyperinflation on chest X-ray or bilateral wheezing, and this infant has clear lower respiratory tract involvement with bilateral wheezing and tachypnea 7, 11
  • Influenza is less likely because it represents only one of multiple viral etiologies, and the clinical presentation is indistinguishable from RSV or other viral causes of bronchiolitis 7, 9

Radiographic Findings

  • The American College of Radiology recommends that chest X-rays should be reserved for consideration of intubation, unexpected clinical deterioration, or underlying cardiac or pulmonary disorder, as routine chest X-rays are not necessary for the diagnosis of bronchiolitis 8, 12, 11
  • Hyperinflation with infiltrates is characteristic of bronchiolitis, reflecting air trapping from small airway obstruction and inflammation 7, 12

Risk Stratification and Management

  • The American Academy of Pediatrics recommends that risk stratification is essential, and at 7 months, assess for risk factors including prematurity, chronic lung disease, congenital heart disease, or immunodeficiency, which would indicate higher risk for severe disease 8